Literature DB >> 29716255

Acoustic vaporization threshold of lipid-coated perfluoropentane droplets.

Mitra Aliabouzar1, Krishna N Kumar1, Kausik Sarkar1.   

Abstract

Phase shift droplets vaporizable by acoustic stimulation offer the advantages of producing microbubbles as contrast agents in situ as well as higher stability and the possibility of achieving smaller sizes. Here, the acoustic droplet vaporization (ADV) threshold of a suspension of droplets with a perfluoropentane (PFP) core (diameter 400-3000 nm) is acoustically measured as a function of the excitation frequency in a tubeless setup at room temperature. The changes in scattered responses-fundamental, sub-, and second harmonic-are investigated, a quantitative criterion is used to determine the ADV phenomenon, and findings are discussed. The average threshold obtained using three different scattered components increases with frequency-1.05 ± 0.28 MPa at 2.25 MHz, 1.89 ± 0.57 MPa at 5 MHz, and 2.34 ± 0.014 MPa at 10 MHz. The scattered response from vaporized droplets was also found to qualitatively match with that from an independently prepared lipid-coated microbubble suspension in magnitude as well as trends above the determined ADV threshold value.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29716255      PMCID: PMC5895468          DOI: 10.1121/1.5027817

Source DB:  PubMed          Journal:  J Acoust Soc Am        ISSN: 0001-4966            Impact factor:   1.840


  52 in total

1.  In vivo microscopy of targeted vessel occlusion employing acoustic droplet vaporization.

Authors:  Stanley Samuel; Ambroise Duprey; Mario L Fabiilli; Joseph L Bull; Jeffrey Brian Fowlkes
Journal:  Microcirculation       Date:  2012-08       Impact factor: 2.628

2.  Effects of Ultrasound Frequency on Nanodroplet-Mediated Histotripsy.

Authors:  Eli Vlaisavljevich; Omer Aydin; Yasemin Yuksel Durmaz; Kuang-Wei Lin; Brian Fowlkes; Mohamed ElSayed; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2015-05-07       Impact factor: 2.998

3.  Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons.

Authors:  Paul S Sheeran; Samantha H Luois; Lee B Mullin; Terry O Matsunaga; Paul A Dayton
Journal:  Biomaterials       Date:  2012-01-29       Impact factor: 12.479

4.  Acoustic droplet vaporization threshold: effects of pulse duration and contrast agent.

Authors:  Andrea H Lo; Oliver D Kripfgans; Paul L Carson; Edward D Rothman; J Brian Fowlkes
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2007-05       Impact factor: 2.725

5.  On the acoustic properties of vaporized submicron perfluorocarbon droplets.

Authors:  Nikita Reznik; Guillaume Lajoinie; Oleksandr Shpak; Erik C Gelderblom; Ross Williams; Nico de Jong; Michel Versluis; Peter N Burns
Journal:  Ultrasound Med Biol       Date:  2014-01-22       Impact factor: 2.998

6.  Microfluidic fabrication of perfluorohexane-shelled double emulsions for controlled loading and acoustic-triggered release of hydrophilic agents.

Authors:  Wynter J Duncanson; Laura R Arriaga; W Lloyd Ung; Jonathan A Kopechek; Tyrone M Porter; David A Weitz
Journal:  Langmuir       Date:  2014-11-11       Impact factor: 3.882

7.  Acoustic droplet vaporization for enhancement of thermal ablation by high intensity focused ultrasound.

Authors:  Man Zhang; Mario L Fabiilli; Kevin J Haworth; Frederic Padilla; Scott D Swanson; Oliver D Kripfgans; Paul L Carson; Jeffrey Brian Fowlkes
Journal:  Acad Radiol       Date:  2011-06-23       Impact factor: 3.173

8.  Development of nanodroplets for histotripsy-mediated cell ablation.

Authors:  Yasemin Yuksel Durmaz; Eli Vlaisavljevich; Zhen Xu; Mohamed ElSayed
Journal:  Mol Pharm       Date:  2014-09-15       Impact factor: 4.939

9.  Effect of anesthesia carrier gas on in vivo circulation times of ultrasound microbubble contrast agents in rats.

Authors:  Lee Mullin; Ryan Gessner; James Kwan; Mehmet Kaya; Mark A Borden; Paul A Dayton
Journal:  Contrast Media Mol Imaging       Date:  2011-01-19       Impact factor: 3.161

Review 10.  Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.

Authors:  Megan M Kaneda; Shelton Caruthers; Gregory M Lanza; Samuel A Wickline
Journal:  Ann Biomed Eng       Date:  2009-01-30       Impact factor: 3.934

View more
  6 in total

1.  Impact of hydrostatic pressure on phase-change contrast agent activation by pulsed ultrasound.

Authors:  Saurabh Raut; Mawia Khairalseed; Arvin Honari; Shashank R Sirsi; Kenneth Hoyt
Journal:  J Acoust Soc Am       Date:  2019-06       Impact factor: 1.840

2.  Acoustic Droplet Vaporization in Acoustically Responsive Scaffolds: Effects of Frequency of Excitation, Volume Fraction and Threshold Determination Method.

Authors:  Mitra Aliabouzar; Xiaofang Lu; Oliver D Kripfgans; J Brian Fowlkes; Mario L Fabiilli
Journal:  Ultrasound Med Biol       Date:  2019-09-25       Impact factor: 2.998

3.  Effects of droplet size and perfluorocarbon boiling point on the frequency dependence of acoustic vaporization threshold.

Authors:  Mitra Aliabouzar; Krishna N Kumar; Kausik Sarkar
Journal:  J Acoust Soc Am       Date:  2019-02       Impact factor: 1.840

4.  Echogenic Exosomes as ultrasound contrast agents.

Authors:  Jenna Osborn; Jessica E Pullan; James Froberg; Jacob Shreffler; Kara N Gange; Todd Molden; Yongki Choi; Amanda Brooks; Sanku Mallik; Kausik Sarkar
Journal:  Nanoscale Adv       Date:  2020-06-18

5.  Contrast-Enhanced Sonography with Biomimetic Lung Surfactant Nanodrops.

Authors:  Alec N Thomas; Kang-Ho Song; Awaneesh Upadhyay; Virginie Papadopoulou; David Ramirez; Richard K P Benninger; Matthew Lowerison; Pengfei Song; Todd W Murray; Mark A Borden
Journal:  Langmuir       Date:  2021-02-10       Impact factor: 3.882

6.  Ultrasound-Sensitive Liposomes for Triggered Macromolecular Drug Delivery: Formulation and In Vitro Characterization.

Authors:  Maria B C de Matos; Roel Deckers; Benjamin van Elburg; Guillaume Lajoinie; Bárbara S de Miranda; Michel Versluis; Raymond Schiffelers; Robbert J Kok
Journal:  Front Pharmacol       Date:  2019-12-05       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.